New Enterprise Associates 16, L.P. is > 10% Shareholder of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 2.19 Million shares of MIRM, which is worth approximately $95.1 Million. The most recent transaction as insider was on Jun 13, 2023, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.19M
0% 3M change
0% 12M change
Total Value Held $95.1 Million

New Enterprise Associates 16, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2023
SELL
Other acquisition or disposition
-
2,000,000 Reduced 47.78%
2,186,243 Common Stock

Also insider at

BHG
Bright Health Group Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
MTCR
Metacrine, Inc. Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
NEA

New Enterprise Associates 16, L.P.

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on MIRM

Follow Mirum Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM